Viewing nowCombinationMoksamentin Tablets 375 mg (Amoxicillin · Clavulanate Potassium (2:1))
Amoxicillin Hydrate 250mg · Dilute Potassium Clavulanate 212.73mg
Tablet · Prescription medication · Combination
JW Pharmaceutical Co., Ltd.

MFDS item code 201309576 · Approved 2013.10.04 · Insurance code 644102320
Treatment of respiratory, ear, genitourinary, skin, bone, and dental infections
This medication is effective against a variety of bacteria and is used for respiratory infections such as acute and chronic bronchitis, pneumonia, empyema, lung abscess, tonsillitis, sinusitis, and otitis media. It is also helpful in treating urinary tract infections like cystitis, urethritis, and pyelonephritis as well as pelvic infections and gonorrhea. It is effective for infections of the skin and soft tissues such as abscesses, wound infections, osteomyelitis, and dental infections. In particular, it can respond to multiple bacterial strains, including resistant strains such as Staphylococcus aureus, Escherichia coli, and Neisseria gonorrhoeae, making it widely applicable. This medication improves patients' symptoms by treating various infections.
The dose of this drug should be determined based on the patient's age, body weight, renal function, and severity of infection. Administer at the start of a meal to minimize potential gastrointestinal intolerance. Absorption of amoxicillin/clavulanate is optimized when administered at the start of a meal. ○ Adults: Administer amoxicillin/potassium clavulanate 250 mg/125 mg per dose orally three times daily, every 8 hours. For severe infections and respiratory tract infections, the dose may be increased to amoxicillin/potassium clavulanate 500 mg/125 mg per dose. ○ For patients with renal impairment, adjust the dose appropriately according to creatinine clearance. - Adults: Dosage adjustment is based on the maximum recommended dose of amoxicillin. No dosage adjustment is necessary for patients with creatinine clearance (CrCl) of 30 mL/min or greater. 10 ~ 30 mL/min: Administer amoxicillin/potassium clavulanate 250mg/125mg or 500mg/125mg per dose every 12 hours. 10 mL/min or less: Administer amoxicillin/potassium clavulanate 250mg/125mg or 500mg/125mg per dose every 24 hours. Hemodialysis: Administer amoxicillin/potassium clavulanate 250mg/125mg or 500mg/125mg per dose every 24 hours, with an additional dose during dialysis and a repeat dose at the end of dialysis. (This is because serum concentrations of both amoxicillin and clavulanate decrease.)
Children 12 years of age or older or weighing 40 kg or more: Administer amoxicillin/potassium clavulanate 250 mg/125 mg per dose orally three times daily, every 8 hours. For severe infections and respiratory tract infections, the dose may be increased to 500 mg/125 mg per dose. Children with renal impairment: Reduce the dose using the same method.
This medication is a beta-lactam antibiotic and should not be administered to patients with a history of hypersensitivity to penicillin or cephalosporin drugs. Patients with viral infections such as infectious mononucleosis or lymphocytic leukemia may have an increased risk of rash when using this medication, so caution is needed. Patients who have previously experienced jaundice or liver dysfunction due to this medication or penicillin-class drugs should avoid its administration due to the risk of recurrence. Patients with impaired liver function should use this medication cautiously, as it may worsen liver function. Patients with moderate to severe renal impairment should adjust dosing intervals, as the drug may accumulate in the body. Those with allergic conditions or family history may easily exhibit allergic symptoms such as skin rashes or asthma; hence, caution is advised. Patients unable to take medication orally, elderly patients, or those in poor general condition may exhibit symptoms of vitamin K deficiency, which requires monitoring. Patients with gastrointestinal diseases such as vomiting or diarrhea may not absorb the medication properly. Gastrointestinal side effects such as diarrhea, vomiting, and abdominal pain may occur, and in severe cases, serious side effects like pseudomembranous colitis may develop, so patients should consult a doctor immediately if symptoms appear. Hematic anomalies may occur, and patients, especially the elderly or males, should undergo regular liver function tests, as symptoms of liver dysfunction may be noticed more frequently in these populations. Rarely, severe skin reactions or anaphylactic shock may occur, and if symptoms such as rashes or breathing difficulties arise, the drug should be stopped immediately and medical personnel should be notified. Blood disorders such as leukopenia, anemia, and thrombocytopenia may occur, and regular blood tests are recommended. Central nervous system side effects such as anxiety, confusion, and seizures may rarely arise, especially in patients with poor renal function or when taking high doses. Acute kidney damage may occur, necessitating regular kidney function tests, and immediate cessation of the medication if abnormalities are found. This medication may affect intestinal flora, causing dysbiosis manifesting as stomatitis or candidiasis; thus, appropriate measures should be taken if symptoms develop. There may be rare occurrences of bleeding tendencies due to vitamin K deficiency or symptoms of vitamin B complex deficiency, necessitating monitoring for associated symptoms. To prevent the development of resistant bacteria, it is crucial to carry out susceptibility testing and use this medication for the minimum necessary duration. Patients with a history of severe hypersensitivity reactions to penicillin should use this medication with extreme caution. During administration, anaphylactic shock may occur, requiring sufficient monitoring and emergency preparedness post-administration. If gastrointestinal symptoms such as diarrhea or abdominal cramps occur, the possibility of pseudomembranous colitis should be considered, and the medication should be stopped immediately. Long-term use may lead to an overgrowth of insensitive bacteria, so close observation is necessary if used beyond 14 days. Patients with signs of liver dysfunction should use this medication cautiously, ensuring that the duration does not exceed 14 days. As renal excretion is the primary route, dose adjustment is needed for patients with renal impairment. In suspected cases of infectious mononucleosis, this medication should be avoided, and drug administration should be stopped immediately if symptoms of skin rashes or serum sickness appear. This medication is not recommended for use in early pregnancy, and during breastfeeding, it may cause side effects in infants, so it should be discontinued upon the development of any abnormal symptoms. This medication is generally not recommended for children under 12 years of age or weighing less than 40 kg due to insufficient usage experience. Elderly patients may experience adverse reactions more easily due to decreased physiological functions, necessitating monitoring of dosage and administration intervals. This medication may affect the results of some clinical tests, so this should be taken into consideration during testing. In cases of overdose, gastrointestinal symptoms, renal failure, seizures, hypersensitivity shock, and other symptoms may occur, requiring the immediate cessation of the medication and appropriate emergency measures.
Diarrhea, pseudomembranous colitis, dyspepsia, stomatitis, gastritis, glossitis, black hairy tongue, nausea, vomiting, loss of appetite, abdominal pain, abdominal distension, constipation, colonic pain, hyperacidity, soft stools, dry mouth, acute pancreatitis, candidiasis, antibiotic-associated colitis, bloody stools, itching, erythema multiforme, Stevens-Johnson syndrome, toxic epidermal necrolysis, vesicular peeling dermatitis, acute generalized exanthematous pustulosis, eosinophilia, angioedema, anaphylaxis, serum sickness syndrome, hypersensitivity vasculitis, bronchospasm, dyspnea, laryngeal edema, anaphylactic shock, leukopenia, thrombocytopenia, hemolytic anemia, anemia, thrombocytopenic purpura, eosinophilia, leukemia, agranulocytosis, lymphocytopenia, thrombocytosis, bone marrow suppression, prolonged bleeding time, prolonged prothrombin time, vaginal itching, vaginal burning, increased secretion, agitation, anxiety, behavior changes, confusion, drowsiness, insomnia, hyperactivity, dizziness, headache, seizures, neck stiffness, fever, altered consciousness, aseptic meningitis, acute kidney failure, interstitial nephritis, hematuria, crystalluria, vitamin K deficiency symptoms, vitamin B complex deficiency symptoms, linear IgA disease, taste disturbance, malaise, dermatitis, oral edema, stomachache, fluid and electrolyte imbalance, rash, hyperactivity, drowsiness, decreased urination, kidney failure, epilepsy, hypersensitivity shock, skin reactions, bleeding, pancytopenia
Not everyone experiences these, and they can vary from person to person.
This medication should be kept in a sealed container to prevent moisture, stored at a cool temperature between 1°C and 25°C. By maintaining this storage condition, the medication's effectiveness can be preserved for a longer period.
White or nearly white oval film-coated tablets
100 tablets (10 tablets in PTP package x 10)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationAmoxicillin Hydrate 250mg · Dilute Potassium Clavulanate 212.73mg
Tablet · Prescription medication · Combination
JW Pharmaceutical Co., Ltd.
CombinationAmoxicillin Hydrate 500mg · Dilute Potassium Clavulanate 215.52mg
Tablet · Prescription medication · Combination
Geonil Pharmaceutical Co., Ltd.
CombinationAmoxicillin Hydrate 125mg · Dilute Potassium Clavulanate 107.76mg
Tablet · Prescription medication · Combination
Geonil Pharmaceutical Co., Ltd.
CombinationAmoxicillin Hydrate 250mg · Dilute Potassium Clavulanate 212.73mg
Tablet · Prescription medication · Combination
International Pharmaceutical Co., Ltd.
CombinationAmoxicillin Hydrate 250mg · Dilute Potassium Clavulanate 215.52mg
Tablet · Prescription medication · Combination
HLB Pharmaceutical Co., Ltd.
CombinationAmoxicillin Hydrate 500mg · Dilute Potassium Clavulanate 215.52mg
Tablet · Prescription medication · Combination
HLB Pharmaceuticals Co., Ltd.
CombinationAmoxicillin Hydrate 250mg · Dilute Potassium Clavulanate 215.52mg
Tablet · Prescription medication · Combination
Dong Sung Pharmaceutical Co., Ltd.
CombinationAmoxicillin Hydrate 250mg · Dilute Potassium Clavulanate 212.73mg
Tablet · Prescription medication · Combination
Youngjin Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.